Regional Collaborations Strengthen Japan’s Neurology Clinical Trials Landscape
The Japan neurology clinical trials market, valued at USD 475.12 million in 2024 and projected to grow at a CAGR of 6.1% from 2025 to 2034, is positioned at the intersection of regional policy innovation and global pharmaceutical collaboration. Japan’s clinical trial ecosystem has gained prominence in the Asia Pacific region due to its aging population, high prevalence of neurological...
0 Comments 0 Shares 624 Views 0 Reviews